Dr Robert M. Brill - 05 Nov 2026 Form 4 Insider Report for CVD EQUIPMENT CORP (CVV)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
06 Nov 2026, 15:09:02 UTC
Prior SEC filing
12 Aug 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Robert Brill
Filing notes and source

Key filing fact

Dr Robert M. Brill filed Form 4 for CVD EQUIPMENT CORP (CVV) on 06 Nov 2026.

Key facts

  • This page summarizes Dr Robert M. Brill's Form 4 filing for CVD EQUIPMENT CORP (CVV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Nov 2026, 15:09.

Change

  • Previous filing in this sequence was filed on 12 Aug 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001008954 Primary reporting owner

BRILL DR ROBERT M

Relationship
Director
Address
C/O CVD EQUIPMENT CORPORATION, 355 S. TECHNOLOGY DRIVE, CENTRAL ISLIP
Signature
Robert Brill
Signature date
06 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVV transaction

Common Stock

Award

Transaction value
Shares
+11,100
Change %
+24%
Price
$0.000000*
Shares after
57,646
Date
05 Nov 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Automatic grant issued on November 5, 2026, the date of the Company's 2026 Annual Meeting of Shareholders, pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan. Twenty-five percent of the shares were fully vested upon grant, and the remaining shares will vest in equal 25% installments on December 31, 2026, March 31, 2027 and June 30, 2027, subject to the recipient's continued service as a Director on each applicable vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .